• Search
  • Helpdesk
  • Sales contact

White Paper

Innovation and Partnerships: The Biotech Perspective

In the ever-evolving landscape of biotechnology, groundbreaking advancements continue to shape the future of healthcare. In this exclusive interview, Estelle Haenel, Chief Medical Officer at Kayentis, engages in a profound...

ePRO data collection: Decision-making for the adoption of a Bring Your Own Device (BYOD) strategy

Electronic devices have been systematically provided to participants to report Patient Reported Outcome (PRO) data in clinical trials and electronic...
,

Decentralized Clinical Trials
Essential tips to avoid common pitfalls

Despite the numerous advantages of Decentralized Clinical Trials, reducing on-site visit means that data endpoints need to be captured via...

Do we have the right understanding of how patients perceive digital clinical trials?

Interview with Trishna Bharadia, Health Advocate & Patient Engagement Advisor on the 1,133 patients survey results conducted by Kayentis in...

BYOD: When, why and how?

What are the main characteristics that make BYOD a strong feature for decentralized trials? What are the key factors to...

eCOA back-up strategies

No longer the “what if” situation: today’s reality and eCOA back-up strategies.How to ensure they are adapted? There have always...

eCOA set-up #whitepaper

How to anticipate eCOA complexities and ensure a successful launch? Setting up a study with eCOA should be straight forward:...

eCOA challenges of long term studies #whitepaper

How to anticipate eCOA complexities in multi-year studies & develop best practice to support sites? Using eCOA solutions can bring...
Follow us on social media
Subscribe to our newsletter
About the author